Director/PDMR Shareholding

RNS Number : 6318V

Kainos Group plc

24 July 2018

 

24 July 2018

Kainos Group plc

("Kainos" or the "Company)

Director / PDMR shareholdings

The Company has been notified that on 24 July 2018, that Paul Gannon, Director, has exercised options over 68,345 ordinary shares of £0.005 at an exercise price of £0.005 per ordinary share.  

Following this notification, Paul Gannon and his Connected Person have a reportable shareholding of 8,499,585 ordinary shares in the issued share capital of the Company, constituting 7.14% of the issued share capital of the Company.

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Paul Gannon
2.	Reason for the notification
a.	Position/status	Business Development Director
b.	Initial notification /Amendment	Initial
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Kainos Group plc
b.	LEI	213800H2PQMIF3OVZY47
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument/ type of instrument Identification code	Ordinary Shares of £0.005 each KNOS
b.	Nature of the transaction	Exercise of Options
c.	Price(s) and volume(s)	Price(s) Volume(s) £0.005 68,345
d.	Aggregated information ·      Aggregated volume ·      Price	N/A
e.	Date of the transaction	2018-07-24
f.	Place of the transaction	LSE - Regulated Market - XLON

Kainos Group Limited Legal Entity Identifier: 213800H2PQMIF3OVZY47 

Ends

For further information, please contact:

Kainos                                                                                         via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Investec Bank plc                                                                                 44 20 7597 5970

Patrick Robb / Sebastian Lawrence

Canaccord Genuity                                                                            [phone]

Simon Bridges / Emma Gabriel

FTI Consulting LLP                                                                            [phone]

Matt Dixon / Harry Staight

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers; and Smart is an automated testing platform for Workday customers.

Kainos has over 1,150 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com
 

 

END

 

 

DSHFKQDPQBKDQOB